Loading…
Anika Therapeutics, Inc.
Anika Therapeutics, Inc. (ANIK) is listed on NASDAQ and classified in Drug Manufacturers - Specialty & Generic, part of the Healthcare sector. It is headquartered in Bedford, United States and has 235 employees. The company is worth $282.25M. Revenue was $112.82M in fiscal 2025, down 5.9% from the year before. It reported a net loss of $10.88M. The share price is 7.8% below its 52-week high of $22.88. 5 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Cliff Asness (AQR Capital Management), at $8.19M. In that quarter, 1 of them opened or added to the position. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Major managers that reported this stock in their latest 13F.
▼ -48.9% over 5Y.
today you would have $479.71▼ -52.0%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 17 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $9.61 | $16.46 | $22.66 | $29.60 | $35.83 | $45.26 | $51.85 | $33.61 | $53.91 | $48.96 | $38.16 | $40.74 | $38.16 | $9.94 | $9.80 | $6.67 | $7.63 | |
| P/E |
Seven formulas applied to the reported numbers, each with its assumption next to the result. None of them predicts a price.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Cash flow growing 5.0% a year for 10 years, discounted at 10%, then 2.5% forever.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| BNTCBenitec Biopharma Inc. | $8.11 | — | 1.6x | 0.00% | -33.21% | $282.9M |
| FULCFulcrum Therapeutics, Inc. | $3.68 | — | 0.9x | 0.00% | -32.38% | $281.09M |
| ARTVArtiva Biotherapeutics, Inc. | $5.85 | — | 0.8x | 0.00% | -36.58% | $286.01M |
| TMCITreace Medical Concepts Inc |
| 23.3x |
| — |
| — |
| — |
| — |
| 128.0x |
| — |
| 27.4x |
| 26.5x |
| 25.5x |
| 22.8x |
| 19.0x |
| 16.2x |
| 27.5x |
| 12.1x |
| 15.8x |
| 20.8x |
| 23.8x |
| P/S | 3.8x | 1.1x | 1.9x | 2.8x | 3.8x | 3.5x | 5.0x | 6.4x | 4.5x | 7.0x | 6.9x | 5.9x | 5.6x | 7.3x | 1.9x | 2.1x | 1.6x | 2.2x |
| P/B | 1.8x | 0.9x | 1.5x | 1.6x | 1.5x | 1.8x | 2.4x | 2.5x | 1.8x | 3.0x | 3.2x | 2.6x | 3.3x | 4.0x | 1.3x | 1.4x | 1.1x | 1.1x |
| EPS | -$0.76 | -$3.83 | -$5.64 | -$1.02 | $0.28 | -$1.69 | $1.89 | $1.27 | $2.11 | $2.15 | $2.01 | $2.51 | $1.39 | $0.82 | $0.62 | $0.32 | $0.32 |
| Profit margin | 13.07% | -9.64% | -47.02% | -68.44% | -13.05% | 2.80% | -18.38% | 23.73% | 17.74% | 28.05% | 31.48% | 33.07% | 36.29% | 27.40% | 16.48% | 13.07% | 7.77% | 9.19% |
| ROE | 7.10% | -7.58% | -36.62% | -38.95% | -5.20% | 1.44% | -8.80% | 9.43% | 7.10% | 12.07% | 14.61% | 14.59% | 21.52% | 15.17% | 10.79% | 8.93% | 5.07% | 4.49% |
Median of the years shown; P/E years above 200x are left out.
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
The average of the method families that answered, not of the seven numbers: four of the seven start from the same earnings per share.
1 methods answered, across 1 families.
Room for errors in the reported numbers.
-54.4% from the average.
Models, not forecasts, and not investment advice. How each formula works →
| $4.28 |
| — |
| 4.1x |
| 0.00% |
| -71.99% |
| $278.35M |
| CLPTClearPoint Neuro, Inc. | $9.07 | — | 25.7x | 0.00% | -226.52% | $276.67M |
| SRZNSurrozen, Inc. | $23.44 | — | — | 0.00% | — | $275.5M |